Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Journal of Cancer Survivorship
Erschienen in: Journal of Cancer Survivorship 3/2013

01.09.2013

Correlates of depressive symptomatology in African-American breast cancer patients

verfasst von: Vanessa B. Sheppard, Adana A. Llanos, Alejandra Hurtado-de-Mendoza, Teletia R. Taylor, Lucile L. Adams-Campbell

Erschienen in: Journal of Cancer Survivorship | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study assessed the levels of depressive symptomatology in African-American women with breast cancer compared to those of women without breast cancer and examined demographic, psychosocial, and clinical factors correlated with depression.

Methods

A total of 152 African-American women were recruited from Washington, DC and surrounding suburbs. Breast cancer patients (n = 76 cases) were recruited from a health care center and women without cancer were recruited from health fairs (n = 76 comparison). We assessed depression, psychosocial variables (ego strength and social support), and sociodemographic factors from in-person interviews. Stage and clinical factors were abstracted from medical records. Independent sample t test, chi square test, analyses of variance, and multiple regression models were used to identify differences in depression and correlates of depression among the cases and comparison groups.

Results

Women with breast cancer reported significantly greater levels of depression (m = 11.5, SD = 5.0) than women without breast cancer (m = 3.9, SD = 3.8) (p < 0.001). Higher cancer stage (beta = 0.91) and higher age (beta = 0.11) were associated with depression in the breast patients, explaining 84 % of the variance. In the comparison group, ego strength and tangible support were inversely associated with depressive symptoms, accounting for 32 % of the variance.

Conclusions

Women with more advanced disease may require interdisciplinary approaches to cancer care (i.e., caring for the whole person).

Implications for Cancer Survivors

Depression is often underrecognized and undertreated in African-American breast cancer patients. Understanding the factors related to depression is necessary to integrate psychosocial needs to routine cancer care to improve survivors’ quality of life.
Literatur
1.
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin. 2009;59:225–49.PubMedCrossRef
2.
Jatoi I, Anderson WF, Rao SR, Devesa SS. Breast cancer trends among Black and White women in the United States. J Clin Oncol. 2005;23:7836–41.PubMedCrossRef
3.
Fawzy FI, Fawzy NW, Arndt LA, Pasnau RO. Critical review of psychosocial interventions in cancer care. Arch Gen Psychiatry. 1995;52:100–13.PubMedCrossRef
4.
Wong-Kim EC, Bloom JR. Depression experienced by young women newly diagnosed with breast cancer. Psychooncology. 2005;14:564–73.PubMedCrossRef
5.
Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan KR, et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry. 2005;58:175–89.PubMedCrossRef
6.
Hjerl K, Andersen EW, Keiding N, Mouridsen HT, Mortensen PB, Jorgensen T. Depression as a prognostic factor for breast cancer mortality. Psychosomatics. 2003;44:24–30.PubMedCrossRef
7.
Fann JR, Thomas-Rich AM, Katon WJ, Cowley D, Pepping M, McGregor BA, et al. Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiatry. 2008;30:112–26.PubMedCrossRef
8.
Jacobsen PB, Wagner LI. A new quality standard: the integration of psychosocial care into routine cancer care. J Clin Oncol. 2012;30:1154–9.PubMedCrossRef
9.
Moore RJ. African American women and breast cancer: notes from a study of narrative. Cancer Nurs. 2001;24:35–42. quiz 43.PubMedCrossRef
10.
Culver JL, Arena PL, Antoni MH, Carver CS. Coping and distress among women under treatment for early stage breast cancer: comparing African Americans, Hispanics and non-Hispanic Whites. Psychooncology. 2002;11:495–504.PubMedCrossRef
11.
Deshields T, Tibbs T, Fan MY, Taylor M. Differences in patterns of depression after treatment for breast cancer. Psychooncology. 2006;15:398–406.PubMedCrossRef
12.
Golden-Kreutz DM, Andersen BL. Depressive symptoms after breast cancer surgery: relationships with global, cancer-related, and life event stress. Psychooncology. 2004;13:211–20.PubMedCrossRef
13.
Davey MP, Kissil K, Nino A, Tubbs CY. “They paid no mind to my state of mind”: African American breast cancer patients' experiences of cancer care delivery. J Psychosoc Oncol. 2010;28:683–98.PubMedCrossRef
14.
Goldstein E. Ego psychology and social work practice. New York: Free; 1995.
15.
Weisman AD. Early diagnosis of vulnerability in cancer patients. Am J Med Sci. 1976;271:187–96.PubMedCrossRef
16.
Sobel HJ, Worden JW. The MMPI as a predictor of psychosocial adaptation to cancer. J Consult Clin Psychol. 1979;47:716–24.PubMedCrossRef
17.
Edgar L, Rosberger Z, Nowlis D. Coping with cancer during the first year after diagnosis. Assessment and intervention. Cancer. 1992;69:817–28.PubMedCrossRef
18.
Berkman LLF. From social integration to health: Durkheim in the new millennium. Soc Sci Med. 2000;51:843–57.PubMedCrossRef
19.
Al-Azri M, Al-Awisi H, Al-Moundhri M. Coping with a diagnosis of breast cancer-literature review and implications for developing countries. Breast J. 2009;15:615–22.PubMedCrossRef
20.
Ashida S, Palmquist AE, Basen-Engquist K, Singletary SE, Koehly LM. Changes in female support network systems and adaptation after breast cancer diagnosis: differences between older and younger patients. Gerontologist. 2009;49:549–59.PubMedCrossRef
21.
Beder J. Perceived social support and adjustment to mastectomy in socioeconomically disadvantaged Black women. Soc Work Health Care. 1995;22:55–71.PubMedCrossRef
22.
Chantler M, Podbilewicz-Schuller Y, Mortimer J. Change in need for psychosocial support for women with early stage breast cancer. J Psychosoc Oncol. 2005;23:65–77.PubMedCrossRef
23.
Gass JS, Weitzen S, Clark M, Dizon DS. Defining social support systems for women with breast cancer. Am J Surg. 2007;194:501–3.PubMedCrossRef
24.
Kang SH, Bloom JR. Social support and cancer screening among older Black Americans. J Natl Cancer Inst. 1993;85:737–42.PubMedCrossRef
25.
Koopman C, Hermanson K, Diamond S, Angell K, Spiegel D. Social support, life stress, pain and emotional adjustment to advanced breast cancer. Psychooncology. 1998;7:101–11.PubMedCrossRef
26.
Kroenke CH, Kubzansky LD, Schernhammer ES, Holmes MD, Kawachi I. Social networks, social support, and survival after breast cancer diagnosis. J Clin Oncol. 2006;24:1105–11.PubMedCrossRef
27.
Lee MK, Park S, Lee ES, Ro J, Kang HS, Shin KH, et al. Social support and depressive mood 1 year after diagnosis of breast cancer compared with the general female population: a prospective cohort study. Support Care Cancer. 2011;19:1379–92.PubMedCrossRef
28.
Liao MMN. Effect of supportive care on the anxiety of women with suspected breast cancer. J Adv Nurs. 2010;66:49–59.PubMedCrossRef
29.
Herndon 2nd AB, Kornblith JE, Zuckerman E, Viscoli CM, Horwitz RI, Cooper MR, et al. Social support as a buffer to the psychological impact of stressful life events in women with breast cancer. Cancer. 2001;91:443–54.PubMedCrossRef
30.
Alloway R, Bebbington P. The buffer theory of social support—a review of the literature. Psychol Med. 1987;17:91–108.PubMedCrossRef
31.
Den Oudsten BL, Van Heck GL, Van der Steeg AF, Roukema JA, De Vries J. Personality predicts perceived availability of social support and satisfaction with social support in women with early stage breast cancer. Support Care Cancer. 2010;18:499–508.CrossRef
32.
Simpson JS, Carlson LE, Beck CA, Patten S. Effects of a brief intervention on social support and psychiatric morbidity in breast cancer patients. Psychooncology. 2002;11:282–94.PubMedCrossRef
33.
Bourjolly JJN. Similarities in coping strategies but differences in sources of support among African American and White women coping with breast cancer. J Psychosoc Oncol. 2001;19:17–38.CrossRef
34.
Anonymous. NCCN practice guidelines for the management of psychosocial distress. National Comprehensive Cancer Network. Oncology (Huntingt). 1999;13:113–147
35.
Shavers VL, Harlan LC, Stevens JL. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer. 2003;97:134–47.PubMedCrossRef
36.
Ford LA. Predictors of psychological functioning in African American women with breast cancer. Unpublished Doctoral Dissertation. 2002.
37.
Beck AT, Rial WY, Rickels K. Short form of depression inventory: cross-validation. Psychol Rep. 1974;34:1184–6.PubMed
38.
Beck AT, Steer RA. Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol. 1984;40:1365–7.PubMedCrossRef
39.
Furlanetto LM, Mendlowicz MV, Romildo Bueno J. The validity of the Beck Depression Inventory-Short Form as a screening and diagnostic instrument for moderate and severe depression in medical inpatients. J Affect Disord. 2005;86:87–91.PubMedCrossRef
40.
Schuldberg D. Ego-strength revised: a comparison of the MMPI-2 and MMPI-1 versions of the Barron Ego-strength scale. J Clin Psychol. 1992;48:500–5.PubMedCrossRef
41.
Norbeck JS, Lindsey AM, Carrieri VL. The development of an instrument to measure social support. Nurs Res. 1981;30:264–9.PubMed
42.
Norbeck JS, Lindsey AM, Carrieri VL. Further development of the Norbeck Social Support Questionnaire: normative data and validity testing. Nurs Res. 1983;32:4–9.PubMedCrossRef
43.
Eskelinen M, Ollonen P. Beck Depression Inventory (BDI) in patients with breast disease and breast cancer: a prospective case–control study. In Vivo. 2011;25:111–6.PubMed
44.
Bell RJ, Lijovic M, La China M, Schwarz M, Fradkin P, Bradbury J, et al. Psychological well-being in a cohort of women with invasive breast cancer nearly 2 years after diagnosis. Support Care Cancer. 2010;18:921–9.PubMedCrossRef
45.
Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, et al. The prevalence of psychiatric disorders among cancer patients. JAMA. 1983;249:751–7.PubMedCrossRef
46.
Karademas EC, Argyropoulou K, Karvelis S. Psychological symptoms of breast cancer survivors: a comparison with matched healthy controls and the association with cancer-related stress and coping. J Psychosoc Oncol. 2007;25:59–74.PubMedCrossRef
47.
Lehto US, Ojanen M, Dyba T, Aromaa A, Kellokumpu-Lehtinen P. Baseline psychosocial predictors of survival in localised breast cancer. Br J Cancer. 2006;94:1245–52.PubMedCrossRef
48.
Massie MJ, Holland JC. Depression and the cancer patient. J Clin Psychiatry. 1990;51 Suppl:12–7. discussion 18–9.PubMed
49.
Spiegel D. Cancer and depression. Br J Psychiatry Suppl. 1996;30:109–16.PubMed
50.
Sheppard VB, Harper FW, Davis K, Hirpa F, Makambi K. The importance of contextual factors and age in association with anxiety and depression in Black breast cancer patients. Psychooncology. 2013 (in press)
51.
Ell K, Sanchez K, Vourlekis B, Lee PJ, Dwight-Johnson M, Lagomasino I, et al. Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer. J Clin Oncol. 2005;23:3052–60.PubMedCrossRef
52.
Osborne RH, Elsworth GR, Hopper JL. Age-specific norms and determinants of anxiety and depression in 731 women with breast cancer recruited through a population-based cancer registry. Eur J Cancer. 2003;39:755–62.PubMedCrossRef
53.
Kornblith AB, Powell M, Regan MM, Bennett S, Krasner C, Moy B, et al. Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer. Psychooncology. 2007;16:895–903.PubMedCrossRef
54.
Siegel KDK. Age-related distress among young women with breast cancer. J Psychosoc Oncol. 1999;17:1–20.CrossRef
55.
Connell SS. Issues and concerns of young Australian women with breast cancer. Support Care Cancer. 2006;14:419–26.PubMedCrossRef
56.
Das AK, Olfson M, McCurtis HL, Weissman MM. Depression in African Americans: breaking barriers to detection and treatment. J Fam Pract. 2006;55:30–9.PubMed
57.
Huang CY, Guo SE, Hung CM, Shih SL, Lee LC, Hung GC, et al. Learned resourcefulness, quality of life, and depressive symptoms for patients with breast cancer. Oncol Nurs Forum. 2010;37:E280–7.PubMedCrossRef
58.
Popoola AO, Adewuya AO. Prevalence and correlates of depressive disorders in outpatients with breast cancer in Lagos, Nigeria. Psychooncology. 2012;21:675–9.PubMedCrossRef
59.
Fulton C. The prevalence and detection of psychiatric morbidity in patients with metastatic breast cancer. Eur J Cancer Care (Engl). 1998;7:232–9.CrossRef
60.
Kissane DW, Clarke DM, Ikin J, Bloch S, Smith GC, Vitetta L, et al. Psychological morbidity and quality of life in Australian women with early-stage breast cancer: a cross-sectional survey. Med J Aust. 1998;169:192–6.PubMed
61.
Maly RC, Umezawa Y, Leake B, Silliman RA. Mental health outcomes in older women with breast cancer: impact of perceived family support and adjustment. Psychooncology. 2005;14:535–45.PubMedCrossRef
62.
Manning-Walsh J. Social support as a mediator between symptom distress and quality of life in women with breast cancer. J Obstet Gynecol Neonatal Nurs. 2005;34:482–93.PubMedCrossRef
63.
Pedersen SS, van Domburg RT, Theuns DA, Jordaens L, Erdman RA. Type D personality is associated with increased anxiety and depressive symptoms in patients with an implantable cardioverter defibrillator and their partners. Psychosom Med. 2004;66:714–9.PubMedCrossRef
64.
Hamilton JB, Sandelowski M. Types of social support in African Americans with cancer. Oncol Nurs Forum. 2004;31:792–800.PubMedCrossRef
65.
Royak-Schaler R, Passmore SR, Gadalla S, Hoy MK, Zhan M, Tkaczuk K, et al. Exploring patient-physician communication in breast cancer care for African American women following primary treatment. Oncol Nurs Forum. 2008;35:836–43.PubMedCrossRef
66.
Sheppard VB, Adams IF, Lamdan R, Taylor KL. The role of patient–provider communication for black women making decisions about breast cancer treatment. Psychooncology. 2011;20:1309–16.PubMedCrossRef
67.
Henderson PD, Gore SV, Davis BL, Condon EH. African American women coping with breast cancer: a qualitative analysis. Oncol Nurs Forum. 2003;30:641–7.PubMedCrossRef
68.
Heilemann MV, Lee KA, Kury FS. Strengths and vulnerabilities of women of Mexican descent in relation to depressive symptoms. Nurs Res. 2002;51:175–82.PubMedCrossRef
69.
Conner KO, Lee B, Mayers V, Robinson D, Reynolds CF, Albert S, et al. Attitudes and beliefs about mental health among African American older adults suffering from depression. J Aging Stud. 2010;24:266–77.PubMedCrossRef
70.
Gonzalez HM, Vega WA, Williams DR, Tarraf W, West BT, Neighbors HW. Depression care in the United States: too little for too few. Arch Gen Psychiatry. 2010;67:37–46.PubMedCrossRef
Metadaten
Titel
Correlates of depressive symptomatology in African-American breast cancer patients
verfasst von
Vanessa B. Sheppard
Adana A. Llanos
Alejandra Hurtado-de-Mendoza
Teletia R. Taylor
Lucile L. Adams-Campbell
Publikationsdatum
01.09.2013
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 3/2013
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-013-0273-y

Weitere Artikel der Ausgabe 3/2013

Journal of Cancer Survivorship 3/2013 Zur Ausgabe

OriginalPaper

Is it safe and efficacious for women with lymphedema secondary to breast cancer to lift heavy weights during exercise: a randomised controlled trial

OriginalPaper

Effectiveness of a patient self-management programme for breast cancer as a chronic illness: a non-randomised controlled clinical trial

OriginalPaper

The EKZ/AMC childhood cancer survivor cohort: methodology, clinical characteristics, and data availability

OriginalPaper

Objectively measured physical activity among US cancer survivors: considerations by weight status

OriginalPaper

Are survivorship care plans responsive to African-American breast cancer survivors?: voices of survivors and advocates

OriginalPaper

Family physician preferences and knowledge gaps regarding the care of adolescent and young adult survivors of childhood cancer

Neu im Fachgebiet Onkologie

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Blutdrucksenkung könnte Uterusmyome verhindern

21.05.2024 Krebsvorsorge in der Gynäkologie Nachrichten

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise